This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Shanghai Genon Bioengineering Co., Ltd, Shanghai Genon Biological Product Co., Ltd., Shanghai Transgenic Research Center. Active years: 2017-2018.
Company Filing History:
Years Active: 2017-2018
Title: Guoxiang Cheng: Innovator in Biotechnology
Introduction
Guoxiang Cheng is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the areas of genetic engineering and protein production. With a total of 2 patents, his work has the potential to impact various industries, including agriculture and food production.
Latest Patents
Cheng's latest patents include a method for positioning and integrating transgenes, which involves a variant loxP element. This innovation allows for more efficient genetic modifications by mutating the sequence 'ATAAT' in a wild type loxP locus to 'CACCT'. The patent also covers constructs and methods for preparing transgenic animals using this technology. Another notable patent is a method for producing low-ash poultry plasma protein powder by utilizing poultry blood. This method includes several steps, such as mixing poultry blood with an anticoagulant, centrifugation, and drying to produce a high-quality protein powder. This invention addresses the challenges of poultry blood processing, promoting resource recycling and reducing environmental pollution.
Career Highlights
Throughout his career, Guoxiang Cheng has worked with notable companies such as Shanghai Genon Bioengineering Co., Ltd and Shanghai Transgenic Research Center. His experience in these organizations has allowed him to develop and refine his innovative ideas in biotechnology.
Collaborations
Cheng has collaborated with several professionals in his field, including Jianquan Chen and Siguo Liu. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Guoxiang Cheng is a noteworthy inventor whose contributions to biotechnology are shaping the future of genetic engineering and protein production. His innovative patents demonstrate his commitment to addressing industry challenges and promoting sustainable practices.